Brainstorm Cell Therapeutics reported $755K in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Biogen USD 29.48B 43.6M Mar/2026
Brainstorm Cell Therapeutics USD 755K 267K Mar/2026
Cipla INR 424.96B 23.32B Mar/2026
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 156.57M 58.73M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Cytokinetics USD 1.27B 151.06M Mar/2026
Gilead Sciences USD 56.28B 2.74B Mar/2026
Grifols EUR 23.15B 142.7M Dec/2025
Halozyme Therapeutics USD 2.67B 147.4M Mar/2026
Mesoblast USD 782.31M 2.38M Dec/2025